In this study, pharmacologic effects of COMT inhibition during sleep deprivation in healthy subjects in dependence of their Val158Met genotype of COMT are studied. Potential effects are identified by measurement of vigilance and cognitive performance as well as EEG measurements during wake and sleep. * Trial with medicinal product
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
30
University of Zurich, Institute of Pharmacology and Toxicology
Zurich, Switzerland
Evolution of vigilance during prolonged wakefulness after intake of tolcapone when compared to placebo
Vigilance is measured subjectively (questionnaires and visual analogue scales) and objectively (e.g., psychomotor vigilance task: reaction times and number of lapses; waking EEG: spectral power) at 3-hour intervals during 40 hours prolonged wakefulness in 30 healthy male adults.
Time frame: Participants will be studied during two weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.